ΔNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck

Journal of Pathology

Volumn 213, Issue 4, 2007, Pages 384-391

  Boldrup, L ^a   Coates, P J ^b   Gu, X ^a   Nylander, K ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Adhesion; CD44; Differentiation; Keratins; P63; Stem cells

Indexed keywords

HERMES ANTIGEN; ISOPROTEIN; KERATIN; PROTEIN P63; CD44 PROTEIN, HUMAN; DNA BINDING PROTEIN; MESSENGER RNA; RNA; TP73L PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; CANCER STEM CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CHROMATIN IMMUNOPRECIPITATION; GEL ELECTROPHORESIS; GENE CONTROL; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOBLOTTING; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; UPREGULATION; BIOSYNTHESIS; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; METABOLISM; METHODOLOGY; MOUTH MUCOSA; PHYSIOLOGY;

ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; KERATINS; MOUTH MUCOSA; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 36749071064     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2237     Document Type: Article

References (46)

1. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V. et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998;2:305-316.
2. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Branson RT, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999;398:714-718.
3. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999;398:708-713.
4. Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, Hill DE, et al. AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA 2000;97:5462-5467.
5. Thurfjell N, Coates PJ, Uusitalo T, Mahani D, Dabelsteen E, Dahlqvist A, et al. Complex p63 mRNA isoform expression patterns in squamous cell carcinoma of the head and neck. Int J Oncol 2004;25:27-35.
6. Thurfjell N, Coates PJ, Boldrup L, Lindgren B, Backlund B, Uusitalo T, et al. Function and importance of p63 in normal oral mucosa and squamous cell carcinoma of the head and neck. Adv Otorhinolaryngol 2005;62:49-57.
7. Barbieri CE, Tang LJ, Brown KA, Pietenpol JA. Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis. Cancer Res 2006;66:7589-7597.
8. Senoo M, Pinto F, Crum CP, McKeon F. p63 is essential for the proliferative potential of stem cells in stratified epithelia. Cell 2007;129:523-536.
9. Parsa R, Yang A, McKeon F, Green H. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J Invest Dermatol 1999;113:1099-1105.
10. Nylander K, Vojtesek B, Nenutil R, Lindgren B, Roos G, Zhanx-iang W, et al. Differential expression of p63 isoforms in normal tissues and neoplastic cells. J Pathol 2002;198:417-427.
11. Vigano MA, Lamartine J, Testoni B, Merico D, Alotto D, Castagnoli C, et al. New p63 targets in keratinocytes identified by a genome-wide approach. EMBO J 2006;25:5105-5116.
12. Yang A, Zhu Z, Kapranov P, McKeon F, Church GM, Gingeras TR, et al. Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells. Mol Cell 2006;24:593-602.
13. Wu G, Nomoto S, Hoque MO, Dracheva T, Osada M, Lee CC, et al. ΔNp63α and Tap63α regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res 2003;63:2351-2357.
14. Koster MI, Dai D, Marinari B, Sano Y, Costanzo A, Karin M, et al. p63 induces key target genes required for epidermal morphogenesis. Proc Natl Acad Sci USA 2007;104:3255-3260.
15. Carroll DK, Carroll JS, Leong CO, Cheng F, Brown M, Mills AA, et al. p63 regulates an adhesion programme and cell survival in epithelial cells. Nat Cell Biol 2006;8:551-561.
16. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 2001;98:31-36.
17. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004;5:R80.
18. Osada M, Park HL, Nagakawa Y, Yamashita K, Fomenkov A, Kim MS, et al. Differential recognition of response elements determines target gene specificity for p53 and p63. Mol Cell Biol 2005;25:6077-6089.
19. Su L, Morgan PR, Lane EB. Keratin 14 and 19 expression in normal, dysplastic and malignant oral epithelia. A study using in situ hybridization and immunohistochemistry. J Oral Pathol Med 1996;25:293-301.
20. Barbieri CE, Perez CA, Johnson KN, Ely KA, Billheimer D, Pietenpol JA. IGFBP-3 is a direct target of transcriptional regulation by ΔNp63α in squamous epithelium. Cancer Res 2005;65:2314-2320.
21. Gu X, Coates PJ, MacCallum SF, Boldrup L, Sjöström B, Nylander K. TRAF4 is potently induced by TAp63 isoforms and localised according to differentiation in SCCHN. Cancer Biol Ther 2007; in press.
22. Friedrichs K, Franke F, Lisboa BW, Kugler G, Gille I, Terpe HJ, et al. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res 1995;55:5424-5433.
23. Nylander K, Coates PJ, Hall PA. Characterization of the expression pattern of p63a and ΔNp63α in benign and malignant oral epithelial lesions. Int J Cancer 2000;87:368-372.
24. Koster MI, Kim S, Mills AA, DeMayo FJ, Roop DR. p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev 2004;18:126-131.
25. Truong AB, Kretz M, Ridky TW, Kimmel R, Khavari PA. p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev 2006;20:3185-3197.
26. Kaya G, Rodriguez I, Jorcano JL, Vassalli P, Stamenkovic I. Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev 1997;11:996-1007.
27. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 2007;104:973-978.
28. Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S, et al. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA 2001;98:3156-3161.
29. + breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006;98:1777-1785.
30. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444:756-760.
31. Van Hal NL, van Dongen GA, Stigter-van Walsum M, Snow GB, Brakenhoff RH. Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma. Int J Cancer 1999;82:837-845.
32. Van Hal NL, Van Dongen GA, Ten Brink CB, Heider KH, Rech-Weichselbraun I, Snow GB, et al. Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma. Clin Cancer Res 1999;5:3534-3541.
33. Franzmann EJ, Weed DT, Civantos FJ, Goodwin WJ, Bourguignon LY. A novel CD44 v3 isoform is involved in head and neck squamous cell carcinoma progression. Otolaryngol Head Neck Surg 2001;124:426-432.
34. Herold-Mende C, Seiter S, Born AI, Patzelt E, Schupp M, Zoller J, et al. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. J Pathol 1996;179:66-73.
35. Fomenkov A, Huang YP, Topaloglu O, Brechman A, Osada M, Fomenkova T, et al. P63α mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells syndrome. J Biol Chem 2003;278:23906-23914.
36. Huang YP, Kim Y, Li Z, Fomenkov T, Fomenkov A, Ratovitski EA. AEC-associated p63 mutations lead to alternative splicing/protein stabilization of p63 and modulation of Notch signaling. Cell Cycle 2005;4:1440-1447.
37. Thornton JK, Dalgleish C, Venables JP, Sergeant KA, Ehrmann IE, Lu X, et al. The tumour-suppressor protein ASPP1 is nuclear in human germ cells and can modulate ratios of CD44 exon V5 spliced isoforms in vivo. Oncogene 2006;25:3104-3112.
38. Bergamaschi D, Samuels Y, Jin B, Duraisingham S, Crook T, Lu X. ASPP1 and ASPP2: common activators of p53 family members. Mol Cell Biol 2004;24:1341-1350.
39. Presland RB, Dale BA. Epithelial structural proteins of the skin and oral cavity: function in health and disease. Crit Rev Oral Biol Med 2000;11:383-408.
40. Ohkura S, Kondoh N, Hada A, Arai M, Yamazaki Y, Sindoh M, et al. Differential expression of the keratin-4, -13, -14, -17 and transglutaminase 3 genes during the development of oral squamous cell carcinoma from leukoplakia. Oral Oncol 2005;41:607-613.
41. Romano RA, Birkaya B, Sinha S. A functional enhancer of keratin 14 is a direct transcriptional target of ΔNp63. J Invest Dermatol 2007;127:1175-1186.
42. Takahashi K, Paladini RD, Coulombe PA. Cloning and characterization of multiple human genes and cDNAs encoding highly related type II keratin 6 isoforms. J Biol Chem 1995;270:18581-18592.
43. Wojcik SM, Bundman DS, Roop DR. Delayed wound healing in keratin 6a knockout mice. Mol Cell Biol 2000;20:5248-5255.
44. Crowe DL, Milo GE, Shuler CF. Keratin 19 downregulation by oral squamous cell carcinoma lines increases invasive potential. J Dent Res 1999;78:1256-1263.
45. Foschini MP, Gaiba A, Cocchi R, Pennesi MG, Gatto MR, Frezza GP, et al. Pattern of p63 expression in squamous cell carcinoma of the oral cavity. Virchows Arch 2004;444:332-339.
46. Lo Muzio L, Santarelli A, Caltabiano R, Rubini C, Pieramici T, Trevisiol L, et al. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma. Hum Pathol 2005;36:187-194.